Andrzej Jakubowiak to Molecular Targeted Therapy
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Molecular Targeted Therapy.
Connection Strength
0.137
-
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. Clin Cancer Res. 2016 Jan 01; 22(1):34-43.
Score: 0.116
-
Monoclonal antibodies in the treatment of multiple myeloma. Br J Haematol. 2011 Sep; 154(6):745-54.
Score: 0.021